We wanted to continue to reassure all our customers that Cherwell Laboratories remains fully operational and is focused on maintaining business as usual, whilst also working hard to minimise the risks for our employees. The ongoing COVID-19 outbreak and the new variants continue to be of great concern. However, the mass vaccination program is providing reassurance of a much improved state by the Summer.
Back in March 2020 we instigated various protective measures such as:
Restricting visitors to site
Increasing availability of hand sanitisers
Introduced additional cleaning around site
Minimised communal area touch points
Deployed home working where possible and practical
Regularly sharing information with employees around identifying symptoms
However, we recognise that COVID-19 will continue to impact our business, staff and communities and that continued vigilance is critical. Therefore, we will continue to:
Reinforce the importance of good hygiene practices and social distancing
Minimise all non-essential business travel and meetings
Review measures and assess ongoing risks
We recognise we are a small piece in an important supply chain, which ultimately serves patients and our existing continuity planning had already identified actions we can take, such as ensuring we retain suitable stock reserves of critical raw materials and finished goods. Our supply chains continue to be quite robust and we will continue to review contingencies with our key suppliers.
We will continue to follow government advice and use this information to update our contingency planning and actions. Please do not hesitate to contact us if you have any questions or concerns regarding supply of products or services.
Growth Promotion Testing: A Guide to Good Practices
Get an in-depth understanding of key considerations and best practices when undertaking growth promotion testing (GPT).
This also guide includes why and how GPT is performed, frequently asked questions and useful references.